Human Life Cord is a manufacturer and seller of regenerative medicines.
Human Life Cord has raised $5.0M in total funding. The most recent round was Series C. The last funding was announced in October 2025.
Human Life Cord's investors include DBJ Capital, Alfresa Holdings, Rohto Pharmaceutical, SRD Holdings, Nihon Trim.
Human Life Cord is headquartered in Tokyo, Japan.
Human Life Cord is a manufacturer and seller of regenerative medicines.
Human Life Cord is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Human Life Cord — Funding & Investors." VCBacked, October 9, 2025, https://www.vcbacked.co/company/human-life-cord. Accessed July 20, 2026.
VCBacked. (2025). Human Life Cord — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/human-life-cord
{{cite web |title=Human Life Cord — Funding & Investors |url=https://www.vcbacked.co/company/human-life-cord |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated